Ro KhannaSell
BMY Common Stock · Transaction Jun 16, 2026 · Filed Jul 6, 2026 · $1,001 to $15,000
NEW YORK STOCK EXCHANGE, INC. · BMY
-0.72% · -$0.4803 · Vol 5.5M
Market closed · last close 4:00 PM ET · price as of 19:20:51 ET
Bristol-Myers Squibb Co
Pharmaceuticals
$66.47
Veridion Score
BETAHIGH CONF · 6/6 factorsFri Aug 28 · market closed · Markets closed · resumes Mon 9:30 ET · BMY
MethodologyBMY
Bristol-Myers Squibb Co
Fri Aug 28 · market closed · Markets closed · resumes Mon 9:30 ET
BUY BIAS
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
70/ 100
Veridion Score
BUY BIAS · HIGH confidence
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6/6 factors with data · Fri Aug 28 · market closed · Markets closed · resumes Mon 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is BMY moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Bristol-Myers Squibb Co
PHARMACEUTICAL PREPARATIONSListed since
1952
Employees
33K
Country
US
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$66.77
Day high
$66.84
Day low
$66.19
Previous close
$66.95
52W high
$67.92
-2.14% from high
52W low
$42.60
94% of range
Market cap
$136.8B
P/E
14.64×
EPS
$4.54
Beta
-0.02
Shares out
2B
Volume
5.5M
0.51× rel vol
Avg volume
10.8M
VWAP
$66.52
Price history computed in-house
1W
-0.81%
1M
+2.48%
3M
+16.25%
1Y
+40.89%
YTD
+23.23%
SMA 50 $61.67 · above
SMA 200 $57.66 · above
52W position 94%
BMY overview
SEC industry peers
BMY peers
Related filings and maps
Public disclosures
Congress activity in BMY
Official filing ↗
Ro KhannaBuy
BMY Common Stock · Transaction May 15, 2026 · Filed Jun 9, 2026 · $1,001 to $15,000
Bristol-Myers Squibb Company Common Stock · Transaction May 7, 2026 · Filed Jun 11, 2026 · $15,001 to $50,000
Ro KhannaBuy
BMY Common Stock · Transaction Apr 13, 2026 · Filed May 11, 2026 · Amount pending receipt enrichment
Bristol-Myers Squibb Company Common Stock · Transaction Mar 27, 2026 · Filed Jul 21, 2026 · $1,001 to $15,000
Federal contracts
BMY contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for BMY in this window.
Lobbying spend
BMY lobbying filings, year to date.
Registered lobbying filings matched to Bristol-Myers Squibb Co.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for BMY in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for BMY.
Options
Sovereign unlock shows live options positioning for BMY.